Results 181 to 190 of about 5,278,927 (357)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Bioinformatics Strategies in Breast Cancer Research. [PDF]

Biomolecules
Veneziano M, Savini I, Cortellesi E, Gasperi V, Gambacurta A, Catani MV.   +5 more
europepmc   +1 more source

Funding cancer research [PDF]

Nature Medicine, 1998
openaire   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

RNA sequencing in ovarian cancer research: a comprehensive review. [PDF]

J Ovarian Res
Shen F, Li C, Li Y, Shen Y, Han F.
europepmc   +1 more source

CANCER RESEARCH

International Journal of Clinical Practice, 1953
openaire   +3 more sources

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Breast cancer: When do you stop reading the literature?

South African Journal of Science, 2016
Brenda Wingfield
doaj   +1 more source

Informatics at the Frontier of Cancer Research. [PDF]

Cancer Res
Noller K, Botsis T, Camara PG, Ciotti L, Cooper LAD, Goecks J, Griffith M, Haas BJ, Ideker T, Karchin R, Kontos D, Lai J, Marcus D, Meyer CA, Naegle K, Pati S, Peters B, Pratt D, Raphael BJ, Reich M, Savova GK, Wright C, Fertig EJ, Bakas S.   +23 more
europepmc   +1 more source

Nutrition Research Funding Trends and Focus Areas at the US National Cancer Institute

, 2022
Elaine B. Trujillo, Cameron Hays, Karen Regan, Sharon A. Ross, Harold E. Seifried   +4 more
openalex   +1 more source